About Chiasma

Chiasma was acquired by Amryt Pharma on August 5, 2021. Amryt is a biopharmaceutical company focused on developing and delivering innovative new treatments to help improve the lives of patients with rare and orphan diseases. Amryt comprises a growing commercial business and a significant development pipeline.

Please Follow us at https://www.linkedin.com/company/amryt-pharma

website icon
Website
employees icon
Employees
industry icon
Industry
Biotechnology
location icon
Headquarter
45 Mespil Road, Dublin, County Dublin D04, IE

Chiasma Alternatives

Industry
biotechnology
Industry
biotechnology
Industry
biotechnology
Industry
biotechnology
Industry
biotechnology

Frequently Asked Questions about Chiasma

Who is the CEO of Chiasma?

Raj K is the CEO of Chiasma. To contact Raj K email at [email protected] or [email protected].

Supercharge your
Prospecting &
Outreach with
ContactOut

Search Portal

Find countless prospects outside of LinkedIn fast

Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.

Discover the source of our data

Learn more